Literature DB >> 28396235

Innate immunity in Sjögren's syndrome.

Jeremy Kiripolsky1, Liam G McCabe1, Jill M Kramer2.   

Abstract

Sjögren's syndrome (SS) is an autoimmune disease of exocrine tissue that primarily affects women. Although patients typically experience xerostomia and xerophthalmia, numerous systemic disease manifestations are seen. Innate immune hyperactivity is integral to many autoimmune diseases, including SS. Results from SS mouse models suggest that innate immune dysregulation drives disease and this is a seminal event in SS pathogenesis. Findings in SS patients corroborate those in mouse models, as innate immune cells and pathways are dysregulated both in exocrine tissue and in peripheral blood. We will review the role of the innate immune system in SS pathogenesis. We will discuss the etiology of SS with an emphasis on innate immune dysfunction. Moreover, we will review the innate cells that mediate inflammation in SS, the pathways implicated in disease, and the potential mechanisms governing their dysregulation. Finally, we will discuss emerging therapeutic approaches to target dysregulated innate immune signaling in SS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A253; Innate immunity; Sjögren's syndrome; Submandibular gland; Toll-like receptor

Mesh:

Year:  2017        PMID: 28396235      PMCID: PMC6025757          DOI: 10.1016/j.clim.2017.04.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  159 in total

1.  Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.

Authors:  M Yamazaki; R Kitamura; S Kusano; H Eda; S Sato; M Okawa-Takatsuji; S Aotsuka; K Yanagi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  RDP58 is a novel and potentially effective oral therapy for ulcerative colitis.

Authors:  Simon Travis; Lee Min Yap; Chris Hawkey; Bryan Warren; Mirella Lazarov; Tim Fong; R J Tesi
Journal:  Inflamm Bowel Dis       Date:  2005-08       Impact factor: 5.325

3.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

4.  Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.

Authors:  Teresa Greenwell-Wild; Niki M Moutsopoulos; Maria Gliozzi; Efstathia Kapsogeorgou; Zoila Rangel; Peter J Munson; Haralampos M Moutsopoulos; Sharon M Wahl
Journal:  Arthritis Rheum       Date:  2011-10

5.  Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.

Authors:  Troy E Daniels; Darren Cox; Caroline H Shiboski; Morten Schiødt; Ava Wu; Hector Lanfranchi; Hisanori Umehara; Yan Zhao; Stephen Challacombe; Mi Y Lam; Yvonne De Souza; Julie Schiødt; Helena Holm; Patricia A M Bisio; Mariana S Gandolfo; Toshioki Sawaki; Mengtao Li; Wen Zhang; Beni Varghese-Jacob; Per Ibsen; Alicia Keszler; Nozomu Kurose; Takayuki Nojima; Edward Odell; Lindsey A Criswell; Richard Jordan; John S Greenspan
Journal:  Arthritis Rheum       Date:  2011-07

6.  Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.

Authors:  Erika Zilahi; Tünde Tarr; Gábor Papp; Zoltán Griger; Sándor Sipka; Margit Zeher
Journal:  Immunol Lett       Date:  2011-10-20       Impact factor: 3.685

7.  Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.

Authors:  Peter Szodoray; Philip Alex; Malin V Jonsson; Nicholas Knowlton; Igor Dozmorov; Britt Nakken; Nicolas Delaleu; Roland Jonsson; Michael Centola
Journal:  Clin Immunol       Date:  2005-08-26       Impact factor: 3.969

Review 8.  Targeting Toll-like receptors in autoimmunity.

Authors:  K S Midwood; A M Piccinini; S Sacre
Journal:  Curr Drug Targets       Date:  2009-11       Impact factor: 3.465

9.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

Authors:  Jacques-Eric Gottenberg; Nicolas Cagnard; Carlo Lucchesi; Franck Letourneur; Sylvie Mistou; Thierry Lazure; Sebastien Jacques; Nathalie Ba; Marc Ittah; Christine Lepajolec; Marc Labetoulle; Marc Ardizzone; Jean Sibilia; Catherine Fournier; Gilles Chiocchia; Xavier Mariette
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B.

Authors:  Z-J Pan; C G Horton; C Lawrence; A D Farris
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

View more
  32 in total

1.  Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.

Authors:  Kaustubh Parashar; Fabian Schulte; Markus Hardt; Olga J Baker
Journal:  FASEB J       Date:  2020-04-11       Impact factor: 5.191

Review 2.  Hearing restoration and the stria vascularis: evidence for the role of the immune system in hearing restoration.

Authors:  Nadia L Samaha; Mohamad M Almasri; J Dixon Johns; Michael Hoa
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2021-10-01       Impact factor: 1.814

3.  Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.

Authors:  Jing Zhou; Bo Ra You; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-11-15       Impact factor: 5.187

4.  Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjögren's syndrome.

Authors:  Jeremy Kiripolsky; Eileen M Kasperek; Chengsong Zhu; Quan-Zhen Li; Jia Wang; Guan Yu; Jill M Kramer
Journal:  J Autoimmun       Date:  2021-02-14       Impact factor: 7.094

Review 5.  Role of inflammasomes in inflammatory autoimmune rheumatic diseases.

Authors:  Young-Su Yi
Journal:  Korean J Physiol Pharmacol       Date:  2017-12-22       Impact factor: 2.016

Review 6.  Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions.

Authors:  Robert Root-Bernstein
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 7.  Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.

Authors:  Pio Conti; Luisa Stellin; Alesssandro Caraffa; Carla E Gallenga; Rhiannon Ross; Spyros K Kritas; Ilias Frydas; Ali Younes; Paolo Di Emidio; Gianpaolo Ronconi
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

8.  Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis.

Authors:  Long Shen; Jing He; Jill M Kramer; Vatinee Y Bunya
Journal:  J Immunol Res       Date:  2019-05-20       Impact factor: 4.818

9.  Characterization of Extracellular Vesicle Cargo in Sjögren's Syndrome through a SWATH-MS Proteomics Approach.

Authors:  Francesco Finamore; Antonella Cecchettini; Elisa Ceccherini; Giovanni Signore; Francesco Ferro; Silvia Rocchiccioli; Chiara Baldini
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

Review 10.  Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges.

Authors:  Weiqian Chen; Ye Yu; Jilin Ma; Nancy Olsen; Jin Lin
Journal:  Stem Cells Int       Date:  2018-09-16       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.